ischemia using a mechanical method of arterial occlusion. De layed (6 hours) reperfusion via mechanical means did not in duce hemorrhage. However, administration of tPA plus delayed mechanical reperfusion significantly increased hemorrhage volumes. Since reperfusion injury was implicated, a final ex periment compared outcomes in spontaneously hypertensive rats treated with tPA plus the free radical spin trap a-phenyl tert butyl nitrone (a-PBN) versus tPA alone. tPA-induced hemor rhage volumes were reduced by 40% with a-PBN, and infarc tion and neurological deficits were also decreased, These re sults indicate that (I) blood pressure is an important correlate of tPA-induced hemorrhage, (2) tPA interacts negatively with reperfusion injury to promote hemorrhage, and (3) combination therapies with anti-free radical treatments may reduce the se verity of tPA-induced hemorrhage and brain injury after cere bral ischemia. Key Words: Cerebral hemorrhage-Oxidative stress-Proteolysis-Reperfusion injury-Stroke-Tissue plasminogen activator. dent models of embolic focal ischemia induced with ho mologous blood clots, delayed treatment with tissue plas minogen activator (tPA) has been observed to result in hemorrhagic transformations (Brinker et aI., 1999; Chopp et aI., 1999; Kano et aI., 1999) .
Here, we describe a quantitative model of tPA induced hemorrhage in rats, and show that whereas blood pressure is an important correlate for hemorrhage, de layed onset of reperfusion per se is not. However, reper fusion injury appeared to interact negatively with tP A to promote hemorrhage. Importantly, combination treat ment with the free radical spin trap a-phenyl tert butyl nitrone (a-PBN) significantly reduced tPA-induced ce rebral hemorrhage and brain injury in embolic focal ischemia.
METHODS AND MATERIALS

Animal models of focal cerebral ischemia
All experiments were performed following an institutionally approved protocol in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Male Wistar Kyoto (WK) rats or spontaneously hypertensive (SH) rats (Taconic, Germantown, NY, U.S.A.) were used. Ani mals were anesthetized with halothane (1-1.2%) under sponta neous respiration in an air-oxygen mixture. Rectal tempera tures were maintained between 37°C to 38°C with a thermostat controlled heating pad. The right femoral artery was cannulated, and physiologic parameters including rectal tem perature, mean arterial blood pressure, pH, Pco2, and P02 were monitored throughout all experiments. The right femoral vein was cannulated for drug administration. Two different modcls of cerebral ischemia were used; an embolic model that uses homologous clots to occlude the middle cerebral artery, and a mechanical model where arterial occlusion is achieved using a silicon-coated filament.
For the embolic model, homologous blood clots were made using methods adapted and modified from Zhang et al (1997) . Briefly, femoral arterial blood from a donor rat was withdrawn into 50 cm of PE-50 tubing and kept in the tube for 2 hours at room temperature, and subsequently retained for 22 hours at 4°C. Five centimeters of the PE-50 tubing containing the clot was cut and connected to a syringe filled with saline using a 23-gauge needle. The clot was transferred into a dish filled with saline and washed. Then the clot was shifted to a modified PE-50 catheter with a 0.3-mm outer diameter filled with saline. Under a surgical microscope (Carl Zeiss, Inc., Thornwood, NY, U.S.A.), a modified PE-50 catheter with a 50-mm long blood clot was gently inserted into the external carotid artery until the tip was positioned just proximal to the origin of middle cerebral artery. Then the clot in the catheter was injected into the inter nal carotid artery along with small amount of saline. After 5 minutes, the catheter was withdrawn from the external carotid artery. Reperfusion was achieved using tPA.
In the appropriate groups, human recombinant tPA (Acti vase, Genentech Inc, San Francisco, CA, U.S.A.) was admin istered intravenously (10 mg/kg in I mL of saline over 30 minutes) using previously established protocols that have been shown to effectively induce clot lysis and cerebral reperfusion in rat embolic stroke (Brinker et aI., 1999; Chopp et aI., 1999; Kano et aI., 1999; Meng et aI., 1999) . The relatively high dose of tPA was chosen based on the approximately tenfold differ ence in fibrin-specific enzyme activity between human and rodent systems (Korninger and Collcn, 1981) .
For the mechanical model of ischemia and reperfusion, a standard intraluminal method was used (Lo et aI., 1998; Zea Longa et aI., 1989) . Under a surgical microscope (Carl Zeiss), the right common, internal, and external carotid arteries were exposed, and a silicon-coated 4.0 nylon monofilament was in serted into the external carotid artery and advanced into the internal carotid artery until the tip occluded the proximal stem of the intracranial middle cerebral artery. Reperfusion was ac complished by removing the filament. To study the effects of tPA plus reperfusion, tPA was also administercd in this me chanical model at the onset of filament withdrawal.
Analysis of infarct volumes and neurological deficits
At 24 hours after ischemia, rats were assessed with a 4-point neurological deficit scale that has been extensively used for rat models of stroke (Bederson et aI., 1986) . After neurological assessment, rats were killed with a lethal overdose of sodium pentobarbital and transcardially perfused to remove all intra vascular blood. Coronal brain sections (2 mm thick) were stained with 2.3.5-triphenyltetrazolium chloride (TTC, Sigma, St. Louis, MO, U.S.A.). Infarct volumes were quantified using computer-assisted image analysis techniques where TTC lesion areas from each slice were integrated to yield total ischemic lesion volumes (Lo et aI., 1998; Newcomb et a!., 1998; Shimizu-Sasamata et a!., 1998) .
Spectrophotometric assay of intracerebral hemorrhage
Cerebral hemorrhage was quantified with a previously de scribed spectrophotometric assay (Choudri et a!., 1997) with some modification. Initially, a standard curve was obtained using a "virtual" model of hemorrhage. Hemispheric brain tis sue was obtained from naive rats subjected to complete trans cardial perfusion to remove intravascular blood. Incremental volumes of homologous blood (0, 2, 4, 8, 16, 32 loLL) were added to each hemispheric sample with phosphate buffered saline (PBS) to reach a total volume of 3 mL, followed by homogenization for 30 seconds, sonication on ice for 1 minute, and centrifugation at 13,000 rpm for 30 minutes. Drabkin's reagent (1.6 mL, Sigma) was added to 0.4 mL aliquots and allowed to stand for 15 minutes at room temperature. Optical density was measured and recorded at 540 nm with a spectro photometer (Spectronix 3000, Milton-Roy, Rochester, NY, U.S.A). These procedures yielded a linear relationship between hemoglobin concentrations in perfused brain and the volume of added blood. Measurements from perfused brains subjected to ischemia and/or tPA reperfusion were compared with this stan dard curve to obtain data in terms of hemorrhage volume (loLL). Hemorrhage measurements were performed on brains already stained with TTC for infarct quantitation. Pilot studies showed that TTC staining did not alter the spectrophotometric hemo globin assay.
Statistical analysis
The major endpoints used in all experiments were infarct volume, hemorrhage volume, and neurological deficits. Data were expressed as mean ± SD. Distributions were checked with Shapiro-Wilks tests and found to be normal, so parametric tests were used. Analysis of variance was used for the multiple group comparisons, followed by Tukey's Honestly Significant Difference tests for inter-group comparisons. Correlations be tween infarct volume and hemorrhage severity were performed using linear regressions.
RESULTS
Experiment 1: tPA-induced hemorrhage and exacerbated brain injury in spontaneously hypertensive rats but not normotensive Wistar-Kyoto rats after embolic focal ischemia Focal cerebral ischemia was induced using homolo gous clot emboli in four groups of rats to examine rates of tPA-induced hemorrhage and brain injury, and its re lationship to blood pressure as a correlate: Group 1 (SH rats no treatment, n = 8), Group 2 (SH rats treated with tP A at 6 hours, n = lO), Group 3 (WK rats no treatment, n = 8), and Group 4 (WK rats treated with tP A at 6 hours, n = 9).
Systemic parameters remained within normal range for all rats, with SH rats showing clear hypertension ( Table 1) . Focal ischemic damage in the middle cerebral artery was present in all occluded rats after 24 hours. In SH rats, tPA induced hemorrhage in the middle cerebral artery territories (Fig. 1) . Hemorrhage severity were sig nificantly increased by tP A when compared with un treated rats (12.3 ± 3.8 mm 3 in tPA-treated rats versus 7.3 ± 2.0 mm 3 in untreated controls, P = 0.001, Fig. 2) . Concomitantly, infarct volumes and neurological deficits were also worsened by tPA (Fig. 2) . The severity of hemorrhage was positively correlated with infarct vol umes (r = 0.611, P < 0.01, Fig. 3A ). There was no correlation between hemorrhage and neurological defi cits.
Overall hemorrhage severity was much lower in nor motensive WK rats (Fig. 1) . Although hemorrhage se verity appeared to be slightly increased by tP A, the dif ference did not reach statistical significance (Fig. 2) . In contrast to the hypertensive SH rats, 24 hour infarct vol umes and neurological deficits were significantly im proved by tPA in normotensive WK rats (Fig. 2) . There was no correlation between hemorrhage severity, infarct volumes, or neurological deficits (Fig. 3B) .
FIG. 1.
Hypertensive SH rats and normotensive Wistar Kyoto (WK) rats were subjected to embolic focal cerebral ischemia. At 6 hours after ischemic onset, rats were treated with tissue plasminogen activator (tPA). tPA induced extensive hemorrhagic transformation in SH rats (A), but not in WK rats (8). Sections were also stained with TIC to show ischemic areas. In hypertensive SH rats subjected to clot-induced embolic stroke (Blood Embolus MCAO), tissue plasminogen activator (tPA) sig nificantly increased hemorrhage volumes compared to untreated rats. Concomitantly, infarct volumes and neurological deficits were worsened as well. The converse was found in normotensive Wistar Kyoto (WK) rats, where treatment with tPA decreased infarction and improved neurological outcomes. Although tPA ap peared to slightly increase hemorrhage in normotensive WK rats, the difference was not statistically significant. In a second animal model (Filament MCAO) where ischemia and reperfusion was induced mechanically, delayed reperfusion per se (RP) or tPA alone did not lead to high rates of hemorrhage. However, the combination of delayed reperfusion plus tPA (RP + tPA) signifi cantly increased hemorrhage volumes. *P < 0.05. The mechanical model of ischemia was used in three groups of rats to determine whether hemorrhage was induced by the onset of delayed reperfusion per se, tP A alone, or negative interactions between reperfusion in jury and tPA: Group I (SH rats subjected to delayed mechanical reperfusion at 6 hours, n = 8), Group 2 (SH rats subjected to permanent focal ischemia and adminis tered tP A at 6 hours, n = 8), and Group 3 (SH rats mechanically reperfused at 6 hours and administered tPA, n = 8).
Systemic parameters were normal in all rats. Twenty four hour infarct volumes were typical for this well described mechanical model of focal cerebral ischemia (Fig. 2) . Delayed reperfusion per se or administration of tP A in permanent focal ischemia did not induce high rates of hemorrhage (Fig. 2) . However, cerebral hemor rhage was significantly elevated in rats exposed to both tPA plus delayed reperfusion (Fig. 2) . Overall hemor rhage severity was lower in this series compared with the embolic clot series in experiment 1. There was no sta tistically detectable difference in infarct volumes or neu rological deficits between all three groups (Fig. 2) . hemorrhage and brain injury in the embolic ischemia model: Group 1 (SH rats treated with tPA at 6 hours, n = 8) and Group 2 (SH rats treated with tP A plus 20 mg/kg a-PBN at 6 hours, n = 8). All systemic parameters were within normal range (Table 1) . Delayed tP A administration induced hemor rhage as expected (Fig. 4) . Combination treatment with a-PBN significantly reduced hemorrhage severity (6.7 ± 4.2 mm 3 in a-PBN plus tPA-treated rats versus Il.l ± 3.8 mm 3 in rats administered tPA alone, P = 0.004, Fig.  4) . Concomitantly, infarct volumes and neurological out comes were significantly improved as well (Fig. 4 ).
DISCUSSION
Thrombolysis with tP A can increase risks of cerebral hemorrhage after ischemic stroke (Larrue et aI., 1999; NINDS rt-PA Stroke Study Group, 1997) . Thus, it is important to dissect the mechanisms involved, and iden tify methods that can ameliorate hemorrhage risks after tP A stroke therapy. In this report, we described a novel quantitative animal model of thrombolysis-induced hem orrhage in ischemic stroke. We showed that (1) blood pressure was a critical correlate because tP A induced hemorrhage in hypertensive SH rats but not normoten sive WK rats, (2) delayed onset of reperfusion per se was not a major factor although tP A appeared to interact negatively with reperfusion injury to promote hemor rhage, and (3) combination treatment with the free radi cal spin trap a-PBN significantly reduced tPA-induced hemorrhage and brain injury after embolic cerebral isch emia.
Clinical data suggest that high systemic blood pressure may increase risks of cerebral hemorrhage (Levy et aI., 1994) . Here, parallel experiments were conducted in nor motensive WK rats, which is the strain most closely re lated to the hypertensive SH rats. Overall, hemorrhage severity was much lower in normotensive WK rats com pared to the SH rats, and tP A did not significantly in crease cerebral hemorrhage. Although we cannot un equivocally exclude a role for other genetic differences Vehicle PBN in the hypertensive SH rats, it is likely that increased blood pressure may be the most parsimonious explana tion here. These data can be interpreted as a validation of our model since the positive correlation between hemor rhage and blood pressure was to be expected. The high rates of hemorrhage in our model may have been caused by the delayed onset of tPA treatment (6 hours postocclusion) rather than being related to tPA thrombolysis per se. To exclude this potential confound, studies were conducted in the standard filament model of arterial occlusion with a delayed onset of mechanical reperfusion at 6 hours. No significant hemorrhage was induced, suggesting that tPA-induced hemorrhage was not solely caused by delayed reperfusion injury. How ever, when tP A was added to the mechanical reperfusion model, hemorrhage rates were significantly elevated. These data suggest that tP A may interact negatively with processes of reperfusion injury, thus leading to damaged cerebrovasculature and hemorrhage. tP A has been shown to amplify excitotoxic and ischemic neuronal injury (Tsirka et aI., 1996 (Tsirka et aI., , 1997 Wang et aI., 1998) . Recently, it was also demonstrated that tP A amplified hemoglobin induced toxicity in neuronal cultures (Wang et aI., 1999) . Similar, albeit undefined, cytotoxic effects of tP A may be involved here.
Reperfusion injury after ischemia involves mecha nisms of oxidative stress and injury (Akins et aI., 1996; Chan, 1996; Hallenback and Dutka, 1990) . Oxidative injury may play a role in mediating cerebrovascular dam age after thrombolytic stroke therapy, thus predisposing brain tissue to hemorrhage (del Zoppo et aI., 1986; Lyden and Zivin, 1993 ). An important finding in the present study was the reduction of tPA-induced hemor rhage and brain injury by the free radical spin trap a-PBN. These findings suggest that compounds targeted against oxidative injury may prove valuable when used as combination treatments for ameliorating hemorrhage risks associated with thrombolytic stroke therapy. Clearly, the underlying molecular mechanisms involved remain to be fully established. However, these data show that tPA-induced hemorrhage can be reduced by combi nation therapies. Additional studies using this model are warranted to explore the mechanisms involved, test therapeutic windows, and translate these findings into clinical applications.
